Table 4 Malaria prevalence (by LM and PCR) by study site
| Â | Lupuna (LUP) | Cahuide (CAH) | Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | % | % [95% CI] | n | % | % [95% CI] | n | % | % [95% CI] | ||||
Microscopy | ||||||||||||
 Total analysed samples (N) | 829 |  |  |  | 1112 |  |  |  | 1941 |  |  |  |
 P. vivax* | 8 | 1.0 | 0.4 | 2.0 | 30 | 2.7 | 1.9 | 3.9 | 38 | 2.0 | 1.4 | 2.7 |
 P. falciparum | 2 | 0.2 | 0.0 | 1.0 | 0 | 0.0 |  |  | 2 | 0.1 | 0.0 | 0.4 |
 Overall* | 10 | 1.2 | 0.6 | 2.3 | 30 | 2.7 | 1.9 | 3.9 | 40 | 2.1 | 1.5 | 2.8 |
 Asymptomatic P. vivax | 3 | 0.4 | 0.1 | 1.1 | 24 | 2.2 | 1.4 | 3.2 | 27 | 1.4 | 0.9 | 2.0 |
 Symptomatic P. vivax | 5 | 0.6 | 0.2 | 1.5 | 6 | 0.5 | 0.2 | 1.2 | 11 | 0.6 | 0.3 | 1.0 |
 Asymptomatic P. falciparum | 1 | 0.1 | 0.0 | 0.8 | 0 | 0.0 |  |  | 1 | 0.1 | 0.0 | 0.3 |
 Symptomatic P. falciparum | 1 | 0.1 | 0.0 | 0.8 | 0 | 0.0 |  |  | 1 | 0.1 | 0.0 | 0.3 |
PCR | ||||||||||||
 Total analysed samples (N) | 777 |  |  |  | 1013 |  |  |  | 1790 |  |  |  |
 P. vivax* | 30 | 3.9 | 2.7 | 5.5 | 63 | 6.2 | 4.8 | 7.9 | 93 | 5.2 | 4.2 | 6.4 |
 P. falciparum* | 9 | 1.2 | 0.6 | 2.3 | 26 | 2.6 | 1.7 | 3.8 | 35 | 2.0 | 1.4 | 2.7 |
 Overall* | 39 | 5.0 | 3.6 | 6.9 | 89 | 8.8 | 7.2 | 10.7 | 128 | 7.2 | 6.0 | 8.5 |
 Asymptomatic P. vivax | 20 | 2.6 | 1.6 | 4.0 | 53 | 5.2 | 4.0 | 6.8 | 73 | 4.1 | 3.2 | 5.1 |
 Symptomatic P. vivax | 10 | 1.3 | 0.7 | 2.4 | 10 | 1.0 | 0.5 | 1.9 | 20 | 1.1 | 0.7 | 1.8 |
 Asymptomatic P. falciparum | 5 | 0.6 | 0.2 | 1.6 | 23 | 2.3 | 1.5 | 3.4 | 28 | 1.6 | 1.1 | 2.3 |
 Symptomatic P. falciparum | 4 | 0.5 | 0.2 | 1.4 | 3 | 0.3 | 0.1 | 0.9 | 7 | 0.4 | 0.2 | 0.8 |
 Sub-patent P. vivax | 22 | 2.8 | 1.8 | 4.3 | 41 | 4.0 | 3.0 | 5.5 | 63 | 3.5 | 2.7 | 4.5 |
 Patent P. vivax | 8 | 1.0 | 0.5 | 2.1 | 22 | 2.2 | 1.4 | 3.3 | 30 | 1.7 | 1.2 | 2.4 |
 Sub-patent P. falciparum | 8 | 1.0 | 0.5 | 2.1 | 26 | 2.6 | 1.7 | 3.8 | 34 | 1.9 | 1.3 | 2.7 |
 Patent P. falciparum | 1 | 0.1 | 0.0 | 0.8 | 0 | 0.0 |  |  | 1 | 0.1 | 0.0 | 0.4 |